Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 2nd Quarter - Report

VIFCARE

via MR. MARK KOPEC

2nd Quarter (Apr 1 - June 30) · 2025Posted Jun 22, 2025Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: VIFCARE
Description: Healthcare Tech
Location: Connecticut · United States of America

Registrant

Firm: MR. MARK KOPEC
Description: consulting firm
Location: Southington, Connecticut, United States of America

Lobbying activities

1 issue

Defense
White paper for view at DECOM. White paper SPARX DEVCOM
Lobbyistsmr MARK A KOPEC
TargetedDefense, Dept of (DOD)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

VIFCARE — Lobbying — Receipts Report